aTyr Pharma Inc.
Organization details
- Legal name
- aTyr Pharma Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- SAN Diego
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ATYR
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001339970
- EIN
- 20-3435077
- Wikidata ID
- Q30286352
Board of directors
-
Eric Benevich · DirectorSince 2024
-
Jane A. Gross · DirectorSince 2023
-
John K. Clarke · DirectorSince 2023
-
Paul Schimmel · DirectorSince 2023
-
Sanjay Shukla · Director · President and CEOSince 2023
-
Sara Zaknoen · DirectorSince 2023
-
Svetlana Lucas · DirectorSince 2023
- Since 2023
Chief executives
Director election results
Annual meeting of May 1, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
86.2%
-
99.6%
Board connections
2 of this board's directors also sit on 5 other boards. 5 are in the same sector.
-
ADC Therapeutics SA Same sectorvia Timothy Coughlin
-
Fate Therapeutics Inc. Same sectorvia Timothy Coughlin
-
Jasper Therapeutics Inc. Same sectorvia Svetlana Lucas
-
Travere Therapeutics Inc. Same sectorvia Timothy Coughlin
-
Vir Biotechnology Inc. Same sectorvia Timothy Coughlin
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $50,000
- 1 purchase by 1 insider
- Sold, last 12 months
- $6,293
- 3 sales by 3 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 27, 2026 | Paul Schimmel Director | Open-market purchase | +100,000 | $0.50 | $50,000 |
| Feb 4, 2026 | Sanjay Shukla Director, Officer (President and CEO) | Open-market sale | −3,745 | $0.98 | $3,670 |
| Feb 4, 2026 | Jill Marie Broadfoot Officer (Chief Financial Officer) | Open-market sale | −1,558 | $0.98 | $1,527 |
| Feb 4, 2026 | DENYES NANCY Officer (General Counsel) | Open-market sale | −1,118 | $0.98 | $1,096 |
| Feb 3, 2026 | Sanjay Shukla Director, Officer (President and CEO) | Option exercise | +10,375 | — | — |
| Feb 3, 2026 | Jill Marie Broadfoot Officer (Chief Financial Officer) | Option exercise | +3,750 | — | — |
| Feb 3, 2026 | DENYES NANCY Officer (General Counsel) | Option exercise | +2,687 | — | — |
| Oct 9, 2025 | Paul Schimmel Director | Open-market purchase | +317,999 | $0.94 | $298,919 |
| Oct 8, 2025 | Paul Schimmel Director | Open-market purchase | +682,001 | $0.90 | $613,801 |
| Mar 17, 2025 | Jane A. Gross Director | Open-market purchase | +3,750 | $4.00 | $15,000 |
| Feb 4, 2025 | Jill Marie Broadfoot Officer (Chief Financial Officer) | Open-market sale | −1,254 | $3.78 | $4,740 |
| Feb 4, 2025 | DENYES NANCY Officer (General Counsel) | Open-market sale | −899 | $3.78 | $3,398 |
| Feb 3, 2025 | Sanjay Shukla Director, Officer (President and CEO) | Option exercise | +10,375 | — | — |
| Feb 3, 2025 | Jill Marie Broadfoot Officer (Chief Financial Officer) | Option exercise | +3,750 | — | — |
| Feb 3, 2025 | DENYES NANCY Officer (General Counsel) | Option exercise | +2,687 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about aTyr Pharma Inc.
Who is the CEO of aTyr Pharma Inc.?
Sanjay Shukla is aTyr Pharma Inc.'s President and CEO.
How many directors are on aTyr Pharma Inc.'s board?
aTyr Pharma Inc.'s board has 8 directors: Eric Benevich, Jane A. Gross, John K. Clarke, Paul Schimmel, Sanjay Shukla, Sara Zaknoen, Svetlana Lucas and Timothy Coughlin.
Are aTyr Pharma Inc. insiders buying or selling shares?
Over the last 12 months, aTyr Pharma Inc. insiders bought $50,000 of shares in 1 purchase and sold $6,293 of shares in 3 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="atyr-pharma-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.